GJD3 and breast carcinoma: Nevertheless, the overexpression of GJD3 mRNA in primary breast cancers that developed brain metastasis was successfully confirmed in a publicly available online dataset of 204 primary breast cancers, when considering only breast cancers which metastasized exclusively to the brain (Supplementary Figure S1c, p = 0.0149).